ATAI Life Sciences N.V.
ATAI
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.67B
Close$
$-0.01
100.1% downside
Current Fair Value
100.1% downsideOvervalued by 100.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.67 Billion |
|---|---|
| Enterprise Value | $1.63 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.91 |
| Beta | 1.6 |
| Outstanding Shares | 226,532,786 |
Return
| Return on Equity | -333.90% |
|---|---|
| Return on Assets | -250.46% |
| Return on Invested Capital | -52.39% |
Valuation & Multiples
| P/E Ratio | -1.55 |
|---|---|
| PEG | -12.2 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 466.79 |
| Enterprise Value to EBIT | -12.95 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$125,000
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$111,111
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2430▲ 3.87% |
|---|---|
| Total Calls | 1,122,400▲ 12.26% |
| Total Puts | 272,700▲ 33.55% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 44.01%▲ 22.58% |
|---|---|
| Total Invested | $357.55M▲ 80.10% |
| Investors Holding | 192▲ 67.00% |
ESG Score
No data
About ATAI Life Sciences N.V.
35 employees